| Trial ID: | L7292 |
| Source ID: | NCT00974051
|
| Associated Drug: |
Terbutaline
|
| Title: |
Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00974051/results
|
| Conditions: |
Type 1 Diabetes
|
| Interventions: |
DRUG: Terbutaline|OTHER: 20% basal insulin reduction|OTHER: Control
|
| Outcome Measures: |
Primary: Blood Glucose Nadir, BG nadir overnight after intervention, overnight hours | Secondary: Percent of Nighttime Glucose Levels <80, 9:00pm to 6:00am|Percent of Nighttime Glucose Levels <70, 10:00pm to 6:00am|Percent of Nighttime Glucose Levels >250 mg/dl, 10:00pm to 6:00am
|
| Sponsor/Collaborators: |
Sponsor: University of Colorado, Denver
|
| Gender: |
ALL
|
| Age: |
CHILD
|
| Phases: |
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-03
|
| Completion Date: |
2008-12
|
| Results First Posted: |
2013-10-11
|
| Last Update Posted: |
2013-10-11
|
| Locations: |
Barbara Davis Center, Aurora, Colorado, 80045, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00974051
|
